東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Inducing cellular senescence in cancer.

Restall, Ian J.

FindBook

Google Book

Amazon

博客來

Inducing cellular senescence in cancer.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Inducing cellular senescence in cancer./
作者:	Restall, Ian J.
面頁冊數:	198 p.
附註:	Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.
Contained By:	Dissertation Abstracts International74-08B(E).
標題:	Chemistry, Biochemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=NR97973
ISBN:	9780494979730

Inducing cellular senescence in cancer.
Restall, Ian J.

Inducing cellular senescence in cancer. - 198 p.

Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.

Thesis (Ph.D.)--University of Ottawa (Canada), 2013.

Cellular senescence is a permanent cell cycle arrest that is induced as a response to cellular stress. Replicative senescence is a well-described mechanism that limits the replicative capacity of cells and must be overcome by cancer cells. Oncogene-induced senescence (OIS) is a form of premature senescence and a potent tumor suppressor mechanism. OIS is induced in normal cells as a result of deregulated oncogene or tumor suppressor gene expression. An exciting area of research is the identification of novel targets that induce senescence in cancer cells as a therapeutic approach. In this study, a novel mechanism is described where the inhibition of Hsp90 in small cell lung cancer (SCLC) cells induced premature senescence rather than cell death. The senescence induced following Hsp90 inhibition was p21-dependent and the loss of p21 allowed SCLC cells to bypass the induction of senescence. Additionally, we identified a novel mechanism where the depletion of PKCiota induced senescence in glioblastoma multiforme (GBM) cells. PKCiota depletion-induced senescence did not activate the DNA-damage response pathway and was p21-dependent. Further perturbations of mitosis, using an aurora kinase inhibitor, increased the number of senescent cells when combined with PKCiota depletion. This suggests that PKCiota depletion-induced senescence involves defects in mitotic progression. Senescent glioblastoma cells at a basal level of senescence in culture, induced by p21 overexpression, and induced after PKCiota depletion had aberrant centrosomes. Mitotic slippage is an early exit from mitosis without cell division that occurs when the spindle assembly checkpoint (SAC) is not satisfied. Senescent glioblastoma cells had multiple markers of mitotic slippage. Therefore, PKCiota depletion-induced senescence involves mitotic slippage and results in aberrant centrosomes. A U87MG cell line with a doxycycline-inducible shRNA targeting PKCiota was developed to deplete PKCiota in established xenografts. PKCiota was depleted in established glioblastoma xenografts in mice and resulted in decreased cell proliferation, delayed tumor growth and improved survival. This study has demonstrated that both Hsp90 and PKCiota are novel targets to induce senescence in cancer cells as a potential therapeutic approach.

ISBN: 9780494979730Subjects--Topical Terms:

1017722
Chemistry, Biochemistry.

Inducing cellular senescence in cancer.
LDR:03173nam a2200289 4500 001 1961883
005 20140722092959.5
008 150210s2013 ||||||||||||||||| ||eng d
020 $a 9780494979730
035 $a (MiAaPQ)AAINR97973
035 $a AAINR97973
040 $a MiAaPQ $c MiAaPQ
100 1 $a Restall, Ian J. $3 2097860
245 1 0 $a Inducing cellular senescence in cancer.
300 $a 198 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.
500 $a Adviser: Ian Lorimer.
502 $a Thesis (Ph.D.)--University of Ottawa (Canada), 2013.
520 $a Cellular senescence is a permanent cell cycle arrest that is induced as a response to cellular stress. Replicative senescence is a well-described mechanism that limits the replicative capacity of cells and must be overcome by cancer cells. Oncogene-induced senescence (OIS) is a form of premature senescence and a potent tumor suppressor mechanism. OIS is induced in normal cells as a result of deregulated oncogene or tumor suppressor gene expression. An exciting area of research is the identification of novel targets that induce senescence in cancer cells as a therapeutic approach. In this study, a novel mechanism is described where the inhibition of Hsp90 in small cell lung cancer (SCLC) cells induced premature senescence rather than cell death. The senescence induced following Hsp90 inhibition was p21-dependent and the loss of p21 allowed SCLC cells to bypass the induction of senescence. Additionally, we identified a novel mechanism where the depletion of PKCiota induced senescence in glioblastoma multiforme (GBM) cells. PKCiota depletion-induced senescence did not activate the DNA-damage response pathway and was p21-dependent. Further perturbations of mitosis, using an aurora kinase inhibitor, increased the number of senescent cells when combined with PKCiota depletion. This suggests that PKCiota depletion-induced senescence involves defects in mitotic progression. Senescent glioblastoma cells at a basal level of senescence in culture, induced by p21 overexpression, and induced after PKCiota depletion had aberrant centrosomes. Mitotic slippage is an early exit from mitosis without cell division that occurs when the spindle assembly checkpoint (SAC) is not satisfied. Senescent glioblastoma cells had multiple markers of mitotic slippage. Therefore, PKCiota depletion-induced senescence involves mitotic slippage and results in aberrant centrosomes. A U87MG cell line with a doxycycline-inducible shRNA targeting PKCiota was developed to deplete PKCiota in established xenografts. PKCiota was depleted in established glioblastoma xenografts in mice and resulted in decreased cell proliferation, delayed tumor growth and improved survival. This study has demonstrated that both Hsp90 and PKCiota are novel targets to induce senescence in cancer cells as a potential therapeutic approach.
590 $a School code: 0918.
650 4 $a Chemistry, Biochemistry. $3 1017722
650 4 $a Biology, Cell. $3 1017686
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0487
690 $a 0379
690 $a 0992
710 2 $a University of Ottawa (Canada). $b Biochemistry, Microbiology and Immunology. $3 2092070
773 0 $t Dissertation Abstracts International $g 74-08B(E).
790 $a 0918
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=NR97973